Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Proposed Operation Warp Speed for Alzheimer’s: an acceleration fund to fast-track cures and slash trillion-dollar costs.
Skye Bioscience, Inc. (Nasdaq: SKYE) ('Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...
Among patients with relapsed or refractory multiple myeloma, Tecvayli (teclistamab-cqyv) monotherapy was associated with a 71 ...
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the ...
The prevalence of serious inflammatory safety issues such as cytokine release syndrome and immune effector cell–associated ...
AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, announced today that the first ...
College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju, North Chungcheong, Republic of Korea Introduction: Alzheimer’s disease (AD) is neurodegenerative disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results